NCT07381296Recruiting
Prognostic Factors and Predictors of Disease Flare in Patients With Rheumatoid Arthritis
Source: ClinicalTrials.gov · Last updated 19 May 2026
Brief summary (registry, in English)
The goal of this observational study is to help find better ways to predict when a flare of your disease (rheumatoid arthritis) might happen. By looking at your registered data, symptoms, disease characteristics, and specific markers in your blood, the investigators hope to help doctors make better decisions about your treatment in the future. The main question it aims to answer is: Can specific patient data, disease characteristics, drug history, or markers in a patient's blood be used to predict when a rheumatoid arthritis flare is about to happen? Participants already diagnosed with rheumatoid arthritis and who have their disease controlled will be followed up every 3 months for any signs or symptoms of a flare.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 25 Jan 2026
- Start date
- 1 Feb 2026
- Primary completion date
- Jun 2027
- Lead sponsor
- Sohag University
- Diseases
- Rheumatoid arthritis
- NCT number
- NCT07381296
What you commit to
- Study type: Observational
- Planned participants: 200
- From 1 Feb 2026 to the primary completion date, Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Any autoimmune disease other than Rheumatoid arthritis. Severe infection, pregnancy, and malignancy.
Age
- Age \< 18 years.
Who the study is looking for
- Age: patients \>18 years old.
- Patients with rheumatoid arthritis diagnosed according to the 2010 American College of Rheumatology (ACR)/European Alliance of Associations for Rheumatology Classification Criteria for RA.
- Clinical remission or low disease activity according to the disease activity score in 28 joints (DAS28).
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Rheumatology and Rehabilitation Department, Faculty of Medicine, Sohag University Coordinator of this site? Confirm its status | Sohag | Egypt | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.